At least three government lawyers working on defending a major Biden-era drug pricing law were laid off in mass cuts across ...
Changes are coming to Medicare costs and coverage in 2024. Announced in time for the annual open enrollment period, which ...
This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...
Prior authorization reforms, increased biosimilar access and the future of the Medicare drug price negotiation program are ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Older Americans have ways to protect against high out-of-pocket health care costs, but it’s important to understand the trade ...
Patient advocacy group Patients for Affordable Drugs (P4AD) yesterday filed its fourth amicus brief defending the Biden ...
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...
GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading into a federal court case over abortion access ...
Robert F. Kennedy Jr. faced a tough confirmation process, seeming unable to understand Medicare and Medicaid. Yet the Senate ...